ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

JUVEDERM VOLUMA XC
Aesthetic medicine
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

JUVEDERM VOLUMA XC PP

Generic Name and Formulations:
Hyaluronic acid 20mg/mL, 0.3% w/w lidocaine; injectable gel implant.

Company:
Allergan

Therapeutic Use:

Indications for JUVEDERM VOLUMA XC:

Cheek augmentation to correct age-related mid-face volume deficit.

Adult:

See full labeling. Inject slowly with least amount of pressure necessary. Wait 3 secs after injecting first small amount before proceeding with rest of the inj. May use supplementary anesthesia during and post-inj. >21yrs: Individualize. Give as small boluses (0.1–0.2mL) by deep inj (subcutaneous and/or supraperiosteal). Max limit: 20mL/60kg per year. May require touch-up treatments to achieve desired effect.

Children:

Not established.

Contraindications:

History of anaphylaxis or presence of multiple severe allergies. Allergies to Gram (+) bacterial proteins, lidocaine.

Warnings/Precautions:

Should only be used by trained and experienced healthcare practitioners. Obtain patient's complete medical history prior to initiation. Avoid intravascular inj; discontinue immediately if changes in vision, signs of stroke, blanching of skin or unusual pain during or shortly after procedure occur. Risk of infection. Defer if active inflammatory process or infection is present at specific sites. Use in non-mid-face areas: not established. Skin injury near treatment site. Known susceptibility to keloid formation, hypertrophic scarring, and pigmentation disorders: not studied. Advise patients to avoid strenuous exercise, extensive sun or heat exposure within first 24hrs. Patients (<35yrs or >65yrs), pregnancy, nursing mothers: not established.

Interactions:

Caution with concomitant immunosuppressants. Increased bruising or bleeding risk at inj sites with concomitant aspirin, NSAIDs, warfarin.

Pharmacological Class:

Dermal filler.

Adverse Reactions:

Inj site reactions (eg, tenderness, swelling, firmness, lumps/bumps, bruising, pain, redness, discoloration, itching); rare: vision impairment, blindness, cerebral ischemia/hemorrhage, stroke, skin necrosis, facial structure damage, late-onset nodules.

Generic Availability:

NO

How Supplied:

Single-use syringe—1 (w. needles)

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs